Report
CRUK has contributed to the development of many cancer drugs in use today. The CRUK-NHS E partnership has calculated the proportion of patients treated with these drugs.
Find out more about how many cancer patients receive a drug CRUK helped to develop - September 2026
Report
Our 2026 report Cancer in the UK: Age aims to support a more nuanced understanding of how cancer prevention, diagnosis, treatment and outcomes vary by age.
Find out more about Cancer in the UK: Age - July 2026
Report
This report summarises the current impact of cancer on people and health services in the UK today. It looks at where progress is being made and what challenges remain.
Find out more about Cancer in the UK: Overview - April 2026
Report
This exploratory analysis estimates the increase in cancer treatment demand in England from the projected increase in cancer incidence over the next decade.
Find out more about future treatment demand - March 2026
Report
This analysis aims to understand disruption from COVID-19 to symptom reporting, waiting times, diagnostics and treatment for bowel and lung cancer patients in Wales.
Find out about the impact of COVID-19 in Wales - April 2025
Report
This report updates the 2020 report and highlights ongoing disparities between the most and least deprived groups.
Find out more about Cancer in the UK: socio-economic deprivation -February 2025
Report
These reports aimed to establish levels of concordance to NICE treatment guideline recommendations for both colon cancer and (NSCLC) non-small cell lung cancer.
Find out more about treatment concordance - November 2024
Peer review publication
This study calculates the cost of initial cancer treatment (surgery, radiotherapy and chemotherapy) by stage at diagnosis for four cancer types in England.
Find out more about costs of first cancer treatment by stage - September 2023
Report
This report looks at the characteristics of patients who face the longest waits for cancer treatment (>104 days from their referral) and the reported reasons for delays.
Find out more about patients experiencing long waits - July 2024
Report
This report from Telstra Health UK and Cancer Research UK explores the impact of the COVID-19 pandemic on cancer surgery and cancer mortality, including place of death.
Find out more about the impact of COVID-19 on surgery and mortality - September 2022
Report
The survey aims to build further understanding on patients' perspectives of how their testing, treatment and wellbeing was impacted by the COVID-19 pandemic.
Find out more about our cancer patient experience survey - July 2021
Peer review publication
This study quantifies geographic variation in the use of lymphadenectomy and/or external-beam radiotherapy (EBRT) for treatment of endometrial cancer in England.
Find out more about variation in endometrial treatment - November 2019
Use this hub to explore treatment data, including proportions which receive different types of treatment, results from audits, and detailed data on radiotherapy.
Visit the archive to view earlier reports and supplementary analyses.
Prevention Policy Research to view our policy on different ways of preventing cancer.
If you have any comments, questions or feedback, please reach out to our team.
Stay up-to-date with the latest cancer research information.
